Home LiteratureArticle Details
PMID: 8635454 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

T cells from baxalpha transgenic mice show accelerated apoptosis in response to stimuli but do not show restored DNA damage-induced cell death in the absence of p53.

The EMBO journal ·Vol. 15 ·No. 6 ·1996-03-15 ·Pages 1221-30

Brady HJ, Salomons GS, Bobeldijk RC, Berns AJ

Abstract

Baxalpha was isolated due to its interaction with Bcl-2. Baxalpha overexpression in an interleukin (IL)-3 dependent cell line accelerates apoptosis upon removal of the cytokine. The ratio of Baxalpha to Bcl-2 appears to be crucial for the effect. To study the action of the bax gene product in vivo, we have generated transgenic mice overexpressing Baxalpha specifically in T cells. Such T cells show accelerated apoptosis in response to gamma-radiation, dexamethasone and etoposide. By crossing baxalpha mice with bcl-2 transgenics we show that the critical nature of the Baxalpha:Bcl-2 ratio holds in primary T cells and that it can be manipulated to elicit a strong response to previously resisted stimuli. p53 has a role in the regulation of apoptosis in response to DNA-damaging agents. p53 directly activates transcription of the bax gene. The presence of the baxalpha transgene accelerated apoptosis in thymocytes from both p53-l- and p53+l- mice in response to dexamethasone. Thymocytes from p53-l- mice with the baxalpha transgene showed similar resistance to apoptosis by DNA-damaging agents as did p53-l- mice without the transgene. Baxalpha overexpression alone cannot restore the DNA damage apoptosis pathway, suggesting that p53 is required to induce or activate other factor(s) to reconstitute the response fully.

MeSH Terms
Animals Apoptosis Base Sequence DNA Damage Glucocorticoids/pharmacology Mice Mice, Transgenic Molecular Sequence Data Proto-Oncogene Proteins/genetics,metabolism Proto-Oncogene Proteins c-bcl-2 Signal Transduction T-Lymphocytes/drug effects,physiology Thymus Gland/cytology Tumor Suppressor Protein p53/genetics,metabolism bcl-2-Associated X Protein
Chemicals
Bax protein, mouse Glucocorticoids Proto-Oncogene Proteins Proto-Oncogene Proteins c-bcl-2 Tumor Suppressor Protein p53 bcl-2-Associated X Protein
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Brady H J
Division of Molecular Genetics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Salomons G S
Bobeldijk R C
Berns A J
References (45)
45 references, click to expand
  1. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2.
    Cell. 1994 Oct 21;79(2):329-39 PMID: 7954799
  2. Activation-induced apoptosis in lymphocytes.
    Curr Opin Immunol. 1994 Jun;6(3):476-87 PMID: 7917117
  3. p53: a cell cycle regulator activated by DNA damage.
    Adv Cancer Res. 1995;66:143-80 PMID: 7793313
  4. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control.
    Cell. 1995 Aug 25;82(4):675-84 PMID: 7664346
  5. Implications of apoptotic cell death regulation in cancer therapy.
    Semin Cancer Biol. 1995 Feb;6(1):53-60 PMID: 7548842
  6. Tumour suppressors, kinases and clamps: how p53 regulates the cell cycle in response to DNA damage.
    Bioessays. 1995 Jun;17(6):501-8 PMID: 7575491
  7. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation.
    Nature. 1980 Apr 10;284(5756):555-6 PMID: 6245367
  8. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells.
    Mol Cell Biol. 1984 Sep;4(9):1689-94 PMID: 6092932
  9. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma.
    Proc Natl Acad Sci U S A. 1986 Jul;83(14):5214-8 PMID: 3523487
  10. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation.
    Cell. 1986 Oct 10;47(1):19-28 PMID: 2875799
  11. An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs.
    Nucleic Acids Res. 1987 Oct 26;15(20):8125-48 PMID: 3313277
  12. Murine CD2 gene expression during fetal thymus ontogeny.
    Eur J Immunol. 1988 Jan;18(1):187-9 PMID: 2450031
  13. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells.
    Nature. 1988 Sep 29;335(6189):440-2 PMID: 3262202
  14. The structure of the human CD2 gene and its expression in transgenic mice.
    EMBO J. 1988 Jun;7(6):1675-82 PMID: 2901953
  15. Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors.
    Cell. 1989 Feb 24;56(4):673-82 PMID: 2537153
  16. bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation.
    Cell. 1989 Apr 7;57(1):79-88 PMID: 2649247
  17. Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53.
    Cell. 1990 Aug 24;62(4):671-80 PMID: 2143698
  18. Epitope tagging and protein surveillance.
    Methods Enzymol. 1991;194:508-19 PMID: 1706460
  19. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry.
    J Immunol Methods. 1991 Jun 3;139(2):271-9 PMID: 1710634
  20. Programmed cell death: apoptosis and oncogenesis.
    Cell. 1991 Jun 28;65(7):1097-8 PMID: 1648446
  21. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6.
    Nature. 1991 Jul 25;352(6333):345-7 PMID: 1852210
  22. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes.
    Cell. 1991 Nov 29;67(5):879-88 PMID: 1835668
  23. bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship.
    Cell. 1991 Nov 29;67(5):889-99 PMID: 1959134
  24. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.
    Nature. 1992 Mar 19;356(6366):215-21 PMID: 1552940
  25. Induction of apoptosis in fibroblasts by c-myc protein.
    Cell. 1992 Apr 3;69(1):119-28 PMID: 1555236
  26. The topoisomerase II inhibitor teniposide (VM-26) induces apoptosis in unstimulated mature murine lymphocytes.
    Exp Cell Res. 1992 Jun;200(2):416-24 PMID: 1315287
  27. Apoptosis and programmed cell death in immunity.
    Annu Rev Immunol. 1992;10:267-93 PMID: 1590988
  28. Cancer. p53, guardian of the genome.
    Nature. 1992 Jul 2;358(6381):15-6 PMID: 1614522
  29. Wild-type p53 is a cell cycle checkpoint determinant following irradiation.
    Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7491-5 PMID: 1323840
  30. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53.
    Cell. 1992 Sep 18;70(6):923-35 PMID: 1356076
  31. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles.
    Cell. 1992 Sep 18;70(6):937-48 PMID: 1525830
  32. p53 is required for radiation-induced apoptosis in mouse thymocytes.
    Nature. 1993 Apr 29;362(6423):847-9 PMID: 8479522
  33. Thymocyte apoptosis induced by p53-dependent and independent pathways.
    Nature. 1993 Apr 29;362(6423):849-52 PMID: 8479523
  34. Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents.
    Blood. 1993 Aug 15;82(4):1092-6 PMID: 8353276
  35. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death.
    Cell. 1993 Aug 27;74(4):609-19 PMID: 8358790
  36. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
    Cell. 1993 Nov 19;75(4):805-16 PMID: 8242751
  37. Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc-induced T-cell lymphoma line.
    Oncogene. 1993 Dec;8(12):3427-31 PMID: 8247547
  38. CD4 cell surface downregulation in HIV-1 Nef transgenic mice is a consequence of intracellular sequestration.
    EMBO J. 1993 Dec 15;12(13):4923-32 PMID: 8262036
  39. Bcl-2 blocks p53-dependent apoptosis.
    Mol Cell Biol. 1994 Apr;14(4):2556-63 PMID: 8139558
  40. Immediate early up-regulation of bax expression by p53 but not TGF beta 1: a paradigm for distinct apoptotic pathways.
    Oncogene. 1994 Jun;9(6):1791-8 PMID: 8183578
  41. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo.
    Oncogene. 1994 Jun;9(6):1799-805 PMID: 8183579
  42. Regulation of apoptosis in the immune system.
    Curr Opin Immunol. 1994 Apr;6(2):279-89 PMID: 8011211
  43. Apoptosis in cancer therapy: crossing the threshold.
    Cell. 1994 Aug 26;78(4):539-42 PMID: 8069905
  44. p53-dependent apoptosis suppresses tumor growth and progression in vivo.
    Cell. 1994 Aug 26;78(4):703-11 PMID: 8069917
  45. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene.
    Cell. 1995 Jan 27;80(2):293-9 PMID: 7834749
Article Info
Journal
The EMBO journal
Abbr.
EMBO J
ISSN
0261-4189
Published
1996-03-15
Pages
1221-30
Language
English
Region
England
NLM ID
8208664
PMCID
PMC450023
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com